USFDA grants Orphan Drug Designation to GSK Benlysta for systemic sclerosis Ruchika Sharma2 Feb 2023 1:15 PM ISTSystemic sclerosis (SSc) is a rare autoimmune disease that causes atypical growth of connective tissues and can affect the musculoskeletal system,...
GSK gets USFDA nod for Benlysta for children with active lupus nephritis Ruchika Sharma29 July 2022 11:39 AM ISTLondon: GSK plc has announced that the US Food and Drug Administration (USFDA) has approved Benlysta (belimumab) for the treatment of children aged 5...
GSK proposal for marketing Belimumab rejected by CDSCO panel Medical Dialogues Team8 July 2021 6:31 PM ISTNew Delhi: In a major setback to GlaxoSmithKline (GSK) Pharmaceuticals, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
GSK gets EMA panel recommendation to approve Benlysta for adult patients with active lupus nephritis Ruchika Sharma29 March 2021 9:30 AM ISTUK: GlaxoSmithKline plc (GSK) has recently announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency...
